Chronic Obstructive Pulmonary Disease News and Research RSS Feed - Chronic Obstructive Pulmonary Disease News and Research

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.
Bacterial invasion of lungs can lead to inflammation in COPD

Bacterial invasion of lungs can lead to inflammation in COPD

Chronic obstructive pulmonary disease (COPD) is a common smoking-related lung illness and the third leading cause of death in the United States. Scientists have long believed that inhaling toxic gases and particles from tobacco smoke causes inflammation of the small airways in the lungs, leading to the development of COPD. However, the theory doesn't explain why airway inflammation and disease progression continue even after the patient stops smoking. [More]
Newly published manuscripts enhance understanding of the immune system

Newly published manuscripts enhance understanding of the immune system

MedImmune, the global biologics research and development arm of AstraZeneca, today announced that it has achieved a significant scientific milestone by publishing three manuscripts in Nature Immunology that advance the understanding of the immune system and highlight underlying mechanisms in two little-understood disease areas -- chronic obstructive pulmonary disease (COPD) and systemic lupus erythematosus (SLE). [More]
Brief exercise program can minimize effects of hospitalization, improve functionality of COPD patients

Brief exercise program can minimize effects of hospitalization, improve functionality of COPD patients

The treatment, designed by scientists at the University of Granada and Virgen de las Nieves Hospital in Granada, allows for cost savings to the health system as it reduces the need for patients to stay in hospital. [More]
Minimally important dyspnoea, fatigue changes in PAH patients defined

Minimally important dyspnoea, fatigue changes in PAH patients defined

Researchers say that a change of around 1 unit in Borg dyspnoea or fatigue scores signifies an important change in patients with pulmonary arterial hypertension. [More]
Cigarette smoking, viral infections may reduce effectiveness of COPD symptom-reliever medication

Cigarette smoking, viral infections may reduce effectiveness of COPD symptom-reliever medication

New study backs up observations in Chronic Obstructive Pulmonary Disease (COPD) patients showing reduced effectiveness of symptom-reliever medication (β2-adrenoceptor agonists) in flare-ups linked to cigarette smoking and infection with viruses such as influenza. [More]
USPSTF does not recommend screening for COPD

USPSTF does not recommend screening for COPD

The U.S. Preventive Services Task Force does not recommend screening for chronic obstructive pulmonary disease (COPD) in persons who do not have symptoms suggestive of COPD. The report appears in the April 5 issue of JAMA. [More]
PneumaCare receives FDA 510(k) clearance for Thora-3DI imaging device

PneumaCare receives FDA 510(k) clearance for Thora-3DI imaging device

PneumaCare Ltd (Cambridge, UK) announced that it has received 510(k) clearance from the US Food and Drug Administration for its Thora-3DI imaging device. [More]
New research finds racial disparities in screening for lung cancer

New research finds racial disparities in screening for lung cancer

New research from the Yale School of Public Health reveals that differences in smoking habits between African Americans and whites may lead to a disparity in screening for lung cancer. [More]
Beta-blockers could have potential benefit for COPD patients

Beta-blockers could have potential benefit for COPD patients

Beta-blockers could be used to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations, according to new findings. [More]
High coronary artery calcium score puts people at greater risk for cancer, kidney disease and COPD

High coronary artery calcium score puts people at greater risk for cancer, kidney disease and COPD

A 10-year follow-up study of more than 6,000 people who underwent heart CT scans suggests that a high coronary artery calcium score puts people at greater risk not only for heart and vascular disease but also for cancer, chronic kidney disease and chronic obstructive pulmonary disease (COPD). [More]
Researchers show how increases in state and local social spending can reduce risk of dying

Researchers show how increases in state and local social spending can reduce risk of dying

Income inequality and government social spending. These are hot-??button issues in this year's presidential primaries: the rich getting richer, the poor getting poorer, and the government's role in closing the gap--or not. [More]
Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Novartis today announced that the United States Food and Drug Administration approved Afinitor (everolimus) tablets for the treatment of adult patients with progressive, well-differentiated, nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic. [More]
New computer program and electronic stethoscope developed to diagnose lung problems

New computer program and electronic stethoscope developed to diagnose lung problems

The classic stethoscope has entered the digital age. Medical researchers have created a computer program that connects to an electronic stethoscope to classify lung sounds into five common diagnostic categories. [More]
UA College of Pharmacy assistant professor developing dry powder inhalers to treat pulmonary diseases

UA College of Pharmacy assistant professor developing dry powder inhalers to treat pulmonary diseases

Heidi M. Mansour, PhD, assistant professor in the University of Arizona College of Pharmacy, is working to develop advanced dry powder inhalers to treat and prevent pulmonary diseases. [More]

ResMed announces definitive agreement to acquire Brightree

ResMed, the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, today announced a definitive agreement to acquire privately held Brightree, a leader in business management and clinical software applications for the post-acute care industry. [More]
Mylan announces FDA's acceptance of ANDA filing for generic Advair Diskus

Mylan announces FDA's acceptance of ANDA filing for generic Advair Diskus

Mylan N.V. today announced that its abbreviated new drug application (ANDA) for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder has been accepted for filing by the U.S. Food and Drug Administration. [More]
Household and outdoor air pollution kills more than 5.5 million people every year

Household and outdoor air pollution kills more than 5.5 million people every year

New research shows that more than 5.5 million people die prematurely every year due to household and outdoor air pollution. More than half of deaths occur in two of the world's fastest growing economies, China and India. [More]
Apellis Pharmaceuticals completes $47.1M Series D preferred stock financing

Apellis Pharmaceuticals completes $47.1M Series D preferred stock financing

Apellis Pharmaceuticals, Inc., today announced that it has completed a $47.1 million Series D preferred stock financing, co-led by new investors Cormorant Asset Management, Hillhouse Capital Group and venBio Global Strategic Fund, joining existing investors Morningside Venture Investments, AJU IB Investment, and Epidarex Capital. [More]
Patients with COPD show decreased gray matter volume in certain areas of the brain

Patients with COPD show decreased gray matter volume in certain areas of the brain

Chronic Obstructive Pulmonary Disease (COPD), a condition impacting nearly 24 million Americans, is often associated with disease-specific fears and avoidance of physical activity. Little is known of the structural brain processes that occur in COPD patients. A study published in the February issue of the journal CHEST found that patients with COPD demonstrated gray matter decreases in areas of the brain that process breathlessness, fear and sensitivity to pain. [More]
Prevalence of past-year generalized anxiety disorder much higher among older adults with COPD

Prevalence of past-year generalized anxiety disorder much higher among older adults with COPD

The prevalence of past-year generalized anxiety disorder (GAD) for adults aged 50 and older with chronic obstructive pulmonary disease (COPD) is much higher compared to older adults without COPD (5.8% vs 1.7%), according to a new study published by University of Toronto researchers. [More]
Advertisement
Advertisement